RT @ScottGottliebMD: I discussed my new essay in @…

RT @ScottGottliebMD: I discussed my new essay in @forbeshealth today on how the drug pricing system of rebates work at an @AEI conference https://t.co/iy4F3HzpfF

@forbeshealth @brucejapsen Current waiver authorit…

@forbeshealth @brucejapsen Current waiver authority is limited both in what can be waived, what feds will waive. Highly complex process.

RT @kimberlyanngeo: Why aren’t we talking more abo…

RT @kimberlyanngeo: Why aren’t we talking more about antibiotic overuse? @bruce_y_lee @forbeshealth onforb.es/1PQ5EPG https://t.co/E5ETXtskjR #antibiotics

RT @kimberlyanngeo: Do #benefits consultants have…

RT @kimberlyanngeo: Do #benefits consultants have the most important jobs in America? @chasedave @forbeshealth onforb.es/1OMt9Kr

Retweeted Forbes Health (@forbeshealth): Prescrip…

Retweeted Forbes Health (@forbeshealth): Prescription opioid disorders are on the rise as overall use falls:… fb.me/7FNz6rybG